The market for Clinical Decision Support Systems (CDSS) is analyzed on a global level. North America will lead the market for CDSS during the forecast period till 2018 due to the availability of sophisticated infrastructure, favorable healthcare policies and government support.
The major players in this market include:
The rise in number of collaborations between third-party CDSS vendors and providers of electronic health records (EHR) is expected to result in highly integrated and seamless experience for users in healthcare organizations. Recently, Elsevier Clinical Decision Support, a care plan and order set vendor, improved the clinical workflow integration under a partnership with EHR providers Allscripts and Epic Systems. Zynx Health was also able to provide similar results in collaboration with Epic Systems and Siemens. Moreover, advanced artificial intelligence technologies such as CDSS developed by IBM's Watson will revolutionize the accessibility of clinical information for informed decision making by physicians and healthcare providers.
The healthcare informatics market is expanding at a great pace across North America and Europe, owing to increased funding for R&D in this sector, both by government and private organizations. Cross-country expansion of the CDSS is still limited due to differences in healthcare laws and language barriers. The market is also expected to slowly expand in South Australia, with the government’s recent introduction of Enterprise Patient Administration System (EPAS) aimed at integrating healthcare information across all the public and private healthcare service providers. Increase in technical awareness and disposable incomes, along with emergence of medical tourism market, will result in growth of CDSS market in Asian countries.
1. Clinical Decision Support Systems - Market Overview
2. Executive Summary
3. Clinical Decision Support Systems - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Clinical Decision Support Systems - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Clinical Decision Support Systems Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
6. Clinical Decision Support Systems Market – By Decision Making Mechanism
6.2. Non Knowledge-based
6.2.1. Artificial Neural Networks
6.2.2. Genetic Algorithms
7. Clinical Decision Support Systems Market – By Applications
7.1. Documentation forms
7.2. Relevant data presentations
7.3. Order creation facilitators
7.4. Protocol support
7.5. Reference information
7.6. Alerts and reminders
8. Clinical Decision Support Systems Market – By Timing Of Use
8.2. During diagnosis
8.3. Post- diagnosis
9. Clinical Decision Support Systems Market – By Mode of Interaction
9.1. Active CDSS
9.2. Passive CDSS
10. Global Clinical Decision Support Systems Market -Geographic Analysis
11. Market Entropy
11.1. New Product Launches
11.2. M&As, Collaborations, JVs and Partnerships
12. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
12.1. Alere Inc.
12.2. Autonomy Corporation plc
12.3. Cerner Multum, Inc.
12.4. EBSCO Industries, Inc.
12.5. Elsevier Clinical Decision Support
12.6. Evidera/ Archimedes Inc.
12.7. FirstDataBank, Inc.
12.8. GIDEON Informatics, Inc.
12.9. IBM Watson
12.10. ICNet International Limited
12.11. Infermedica Sp. z o.o
12.12. Isabel Healthcare Inc.
12.13. Logical images, Inc
12.14. Massachusetts General Hospital
12.15. McKesson Corporation
12.16. Pepid, LLC
12.17. Philips Healthcare
12.18. Sharecare, Inc.
12.19. SimulConsult Inc.
12.20. Truven Health Analytics, Inc.
12.21. T-System Inc.
12.22. Wolters Kluwer Health, Inc.
12.23. Zynx Health Incorporated
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13.3. Research Methodology
13.5. Compilation of Expert Insights